Call for proposals for feasibility studies has now closed
Feasibility Studies Funding
The deadline for the submission of applications for funding of up to £100,000 to support feasibility studies has now passed.
Funding will be awarded in September 2020.
Vax-Hub is pleased to announce the award of interaction vouchers to support the following collaborative activity.
|Hilleman Labs & UCL||Establishing the use of microscale chromatography-for downstream process optimization of Group B streptococcus polysaccharides|
|Phenotypeca Ltd and the University of Oxford||Exploiting the genetic diversity of Saccharomyces cerevisiae for VLP production|
|Sartorius Stedim Biotech and the University of Oxford||Cost of goods evaluation of adenovirus-based vaccine against Coronavirus|
|Sartorius Stedim Biotech and the University of Oxford||Improving scalability and productivity of an adenovirus-based vaccine against Coronavirus|
|Univercells, University of Leeds & UCL||Proof of principle synthesis of polio virus-like particles in an E. coli cell-free manufacturing platform|
|Vironova and UCL||MiniTEM analysis: characterisation of Viral Vaccines, Vectors and VLPs|
Platform funding will be awarded to members* of the Vax-Hub Users Group only. If you are not currently a member of the Hub but would be interested in joining to access this and other Hub benefits, please contact Jane Doogan, Vax-Hub Project Manager: firstname.lastname@example.org